GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Nhu Co Ltd (SZSE:002001) » Definitions » Price-to-Owner-Earnings

Zhejiang Nhu Co (SZSE:002001) Price-to-Owner-Earnings : 157.42 (As of Sep. 21, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Zhejiang Nhu Co Price-to-Owner-Earnings?

As of today (2024-09-21), Zhejiang Nhu Co's share price is ¥18.89. Zhejiang Nhu Co's Owner Earnings per Share (TTM) ended in Jun. 2024 was ¥0.12. It's Price-to-Owner-Earnings for today is 157.42.


The historical rank and industry rank for Zhejiang Nhu Co's Price-to-Owner-Earnings or its related term are showing as below:

SZSE:002001' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 13.6   Med: 62.34   Max: 9689.54
Current: 160.09

During the past 13 years, the highest Price-to-Owner-Earnings of Zhejiang Nhu Co was 9689.54. The lowest was 13.60. And the median was 62.34.


SZSE:002001's Price-to-Owner-Earnings is ranked worse than
91.18% of 431 companies
in the Drug Manufacturers industry
Industry Median: 25.44 vs SZSE:002001: 160.09

As of today (2024-09-21), Zhejiang Nhu Co's share price is ¥18.89. Zhejiang Nhu Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was ¥1.10. Therefore, Zhejiang Nhu Co's PE Ratio for today is 17.17.

As of today (2024-09-21), Zhejiang Nhu Co's share price is ¥18.89. Zhejiang Nhu Co's EPS without NRI for the trailing twelve months (TTM) ended in was ¥1.15. Therefore, Zhejiang Nhu Co's PE Ratio without NRI for today is 16.37.

During the past 13 years, Zhejiang Nhu Co's highest PE Ratio without NRI was 55.08. The lowest was 8.45. And the median was 19.35.


Zhejiang Nhu Co Price-to-Owner-Earnings Historical Data

The historical data trend for Zhejiang Nhu Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Nhu Co Price-to-Owner-Earnings Chart

Zhejiang Nhu Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 65.52 49.78 347.22 -

Zhejiang Nhu Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 162.71

Competitive Comparison of Zhejiang Nhu Co's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Nhu Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Nhu Co's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Nhu Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Zhejiang Nhu Co's Price-to-Owner-Earnings falls into.



Zhejiang Nhu Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Zhejiang Nhu Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=18.89/0.12
=157.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Nhu Co  (SZSE:002001) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Zhejiang Nhu Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Zhejiang Nhu Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Nhu Co Business Description

Traded in Other Exchanges
N/A
Address
No. 4 Jiangbei Road, Yulin Street, Xinchang County, Zhejiang Province, Shaoxing, CHN, 312500
Zhejiang Nhu Co Ltd is a China-based company engaged in the manufacture and sales of pharmaceuticals, health protection products, pharmaceutical intermediates, fragrances, food additives and feed additives. The company's active pharmaceutical ingredient products cover various areas such as Cardiovascular, Anti-AIDS, Anti-cancer and Anti-bacterial with key products such as Latamoxef Sodium, Flomoxef Sodium, Hydrochloride Moxifloxacin, Artemisinin series, Calcium Keto acid series, Vitamin A/E/D3 and coenzyme Q10 and others. The other business areas are Aroma chemicals, Polymers, and Nutrition. The organization markets its products in China and internationally.
Executives
Hu Bai Fan Director
Shi Guan Qun Directors, Directors, and Executives
Hu Bai Shan Directors, executives
Cui Xin Rong Director
Chen Xue Cao Supervisors
Zhou Gui Yang Director
Qiu Jin Zhuo Supervisors
Wang Xue Wen Directors, executives
Wang Zheng Jiang Director
Ye Yue Heng Director
Dong Xiao Fang Supervisors
Liang Xiao Dong Supervisors
Zhang Xiao Bo Supervisors
Wang Xu Lin Supervisors
Ding Zhong Jun Director

Zhejiang Nhu Co Headlines

No Headlines